Description
iPSC-derived CD34+ Cells, BXS0117 are induced pluripotent stem cells that have been differentiated into hematopoietic progentitor CD34+ cells. These cells can be further differentiated down common lymphoid progenitor and common myeloid progenitor lineages. iPSC-derived CD34+ Cells can be used in cancer immunology research, drug development, toxicity screening, and blood lineage differentiation studies